{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:48:47Z","timestamp":1791611327656,"version":"4.3.4"},"reference-count":14,"publisher":"Japanese Urological Association","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. j. urol"],"published-print":{"date-parts":[[2026,7,20]]},"DOI":"10.5980\/jpnjurol.117.69","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:13:30Z","timestamp":1791497610000},"page":"69-73","source":"Crossref","is-referenced-by-count":0,"title":["A CASE OF PENILE CANCER WITH PELVIC LYMPH NODE METASTASIS SUCCESSFULLY TREATED WITH SIMULTANEOUS INGUINAL AND PELVIC LYMPH NODE DISSECTION AFTER TIP-BASED NEOADJUVANT CHEMOTHERAPY","\u9670\u830e\u764c\u9aa8\u76e4\u30ea\u30f3\u30d1\u7bc0\u8ee2\u79fb\u306b\u5bfe\u3057TIP\u306b\u3088\u308b\u8853\u524d\u88dc\u52a9\u5316\u5b66\u7642\u6cd5\u3068\u4e21\u5074\u9f20\u5f84\u30fb\u9aa8\u76e4\u30ea\u30f3\u30d1\u7bc0\u540c\u6642\u90ed\u6e05\u306b\u3088\u308a\u6839\u6cbb\u3092\u5f97\u305f\u4e00\u4f8b"],"prefix":"10.5980","volume":"117","author":[{"given":"Suguru","family":"Ito","sequence":"first","affiliation":[{"name":"Department of Urology, Yamagata University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Nishida","sequence":"additional","affiliation":[{"name":"Department of Urology, Yamagata University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadanobu","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Urology, Okitama General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigemitsu","family":"Horie","sequence":"additional","affiliation":[{"name":"Department of Urology, Okitama General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Kanno","sequence":"additional","affiliation":[{"name":"Department of Urology, Okitama General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"Department of Urology, Yamagata University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4001","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Tanaka K, Kandori S, Nitta S, Chihara I, Kojo K, Nagumo Y, Kimura T, Kojima T, Kawai K, Okuyama A, Higashi T and Nishiyama H: Characteristics of penile cancer in Japan: An analysis of nationwide hospital-based cancer registry data. Int J Urol, 27, 538-542, 2020.","DOI":"10.1111\/iju.14247"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Jeanne-Julien A, Bouchot O, De Vergie S, Branchereau J, Perrouin-Verbe MA and Rigaud J: Long-term oncological results in penile cancer treated by inguinal lymphadenectomy. World J Urol, 41, 1589-1595, 2023.","DOI":"10.1007\/s00345-023-04390-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Pagliaro LC, Williams DL, Daliani D, Williams MB, Osai W, Kincaid M, Wen S, Thall PF and Pettaway CA: Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: A phase II study. J Clin Oncol, 28, 3851-3857, 2010.","DOI":"10.1200\/JCO.2010.29.5477"},{"key":"4","unstructured":"4) \u4e45\u4fdd\u7530\u6075\u7ae0, \u4ef2\u91ce\u6b63\u535a, \u6c38\u4e95\u771f\u543e, \u677e\u5ca1\u52a0\u6075, \u8352\u5ddd\u88d5\u8cb4, \u5800\u6c5f\u61b2\u543e, \u51fa\u53e3 \u9686, \u52a0\u85e4\u4e45\u548c: TIP (Paclitaxel, Ifosfamide, Cisplatin) \u7642\u6cd5\u304c\u8457\u52b9\u3057\u305f\u9f20\u5f84\u30ea\u30f3\u30d1\u7bc0\u8ee2\u79fb\u3092\u6709\u3059\u308b\u9670\u830e\u764c\u306e1\u4f8b. \u6ccc\u5c3f\u7d00\u8981, 61, 33-37, 2015."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Matsuda Y, Nishiyama N, Shindo T and Masumori N: Clinical features of 4 patients who underwent neoadjuvant chemotherapy for the locally advanced penile cancer. Int Cancer Conf J, 6, 76-79, 2017.","DOI":"10.1007\/s13691-017-0278-x"},{"key":"6","unstructured":"6) \u6238\u9ad8\u96c5\u5e83, \u4e95\u4e0a \u4eab, \u4e09\u6728\u5927\u8f14, \u9ad8\u6a4b \u525b, \u6b66\u4e95\u822a\u5e73, \u7532\u6590\u535a\u5b9c, \u5ca9\u5d0e\u548c\u7bc4, \u6f81\u8c37\u5fe0\u6b63, \u5e73\u4e95\u5065\u4e00, \u5b89\u85e4\u5fe0\u52a9, \u79e6 \u8061\u5b5d, \u4e09\u80a1\u6d69\u5149: \u30ea\u30f3\u30d1\u7bc0\u8ee2\u79fb\u3092\u6709\u3059\u308b\u9670\u830e\u764c\u306b\u5bfe\u3057\u3066\u8853\u524dTIP\u7642\u6cd5\u304c\u6709\u52b9\u3067\u3042\u3063\u305f1\u4f8b. \u897f\u65e5\u6ccc\u5c3f, 82, 308-312, 2020."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) \u80fd\u767b\u7d00\u5f70, \u677e\u672c\u73b2\u5fdc\u5948, \u6d45\u91ce \u6f64, \u671b\u6708 \u62d3, \u6c34\u91ce\u4f38\u5f66, \u5343\u8449\u559c\u7f8e\u7537: TIP (Paclitaxel, Ifosfamide, Cisplatin) \u7642\u6cd5\u304c\u8457\u52b9\u3057\u305f\u9670\u830e\u764c\u9aa8\u76e4\u30fb\u9f20\u5f84\u30ea\u30f3\u30d1\u7bc0\u518d\u767a\u306e1\u4f8b. \u65e5\u6ccc\u5c3f\u4f1a\u8a8c, 115, 80-84, 2024.","DOI":"10.5980\/jpnjurol.115.80"},{"key":"8","unstructured":"8) \u65e5\u672c\u6ccc\u5c3f\u5668\u79d1\u5b66\u4f1a\u7de8: \u9670\u830e\u764c\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3. 2021\u5e74\u7248, \u91d1\u539f\u51fa\u7248, \u6771\u4eac, 2021."},{"key":"9","unstructured":"9) National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: Penile Cancer. Version 2.2025, National Comprehensive Cancer Network, 2025."},{"key":"10","unstructured":"10) European Association of Urology and American Society of Clinical Oncology: EAU-ASCO Collaborative Guidelines on Penile Cancer, 2025."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Rose KM, Pham R, Zacharias NM, Ionescu F and Paravathaneni M: Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: An international, multi-institutional, real-world study. J Natl Cancer Inst, 116, 966-973, 2024.","DOI":"10.1093\/jnci\/djae034"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Saisorn I, Lawrentschuk N, Leewansangtong S and Bolton DM: Fine-needle aspiration cytology predicts inguinal lymph node metastasis without antibiotic pretreatment in penile carcinoma. BJU Int, 97, 1225-1228, 2006.","DOI":"10.1111\/j.1464-410X.2006.06159.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Sadeghi R, Gholami H, Zakavi SR, Kakhki VRD and Horenblas S: Accuracy of 18F-FDG PET\/CT for diagnosing inguinal lymph node involvement in penile squamous cell carcinoma: systematic review and meta-analysis of the literature. Clin Nucl Med, 37, 436-441, 2012.","DOI":"10.1097\/RLU.0b013e318238f6ea"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Subir\u00e1-R\u00edos D, Ca\u00f1o-Velasco J, Moncada-Iribarren I, Gonz\u00e1lez-Garc\u00eda J, Polanco-Pujol L, Subir\u00e1-Rios J and Hern\u00e1ndez-Fern\u00e1ndez C: Pelvic and inguinal single-site approach: PISA technique. New minimally invasive technique for lymph node dissection in penile cancer. Actas Urol Esp (Engl Ed), 46, 150-158, 2022.","DOI":"10.1016\/j.acuroe.2022.02.006"}],"container-title":["The Japanese Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/117\/3\/117_69\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:55:30Z","timestamp":1791608130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/117\/3\/117_69\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5980\/jpnjurol.117.69","relation":{},"ISSN":["0021-5287","1884-7110"],"issn-type":[{"value":"0021-5287","type":"print"},{"value":"1884-7110","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]}}}